We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 PR Newswire LONDON, April 25, 2024 LONDON, April 25, 2024...
Virax Biolabs to Participate at ESCMID Global 2024 PR Newswire LONDON, April 16, 2024 LONDON, April 16, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company...
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency PR Newswire LONDON, March 15, 2024 LONDON, March 15, 2024 /PRNewswire/ -- Virax Biolabs Group...
Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.15 | 1.41776937618 | 10.58 | 10.58 | 10.58 | 499 | 10.58 | DE |
4 | -0.7 | -6.12423447069 | 11.43 | 11.93 | 10.19 | 394 | 10.93871197 | DE |
12 | -1.26 | -10.5087572977 | 11.99 | 13.44 | 10.19 | 296 | 11.50806033 | DE |
26 | -0.51 | -4.53736654804 | 11.24 | 15.72 | 10.19 | 582 | 12.39816438 | DE |
52 | 4.33 | 67.65625 | 6.4 | 15.72 | 5.5 | 552 | 11.07055203 | DE |
156 | 4.33 | 67.65625 | 6.4 | 15.72 | 5.5 | 552 | 11.07055203 | DE |
260 | 4.33 | 67.65625 | 6.4 | 15.72 | 5.5 | 552 | 11.07055203 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions